申请人:Korea Research Institute of Chemical Technology
公开号:US20130078256A1
公开(公告)日:2013-03-28
The invention is related to compounds of Formula (I):
or a pharmaceutically acceptable salt, solvate, ester, and/or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
本发明涉及式(I)的化合物:或其药学上可接受的盐、溶剂、酯和/或膦酸酯,包含这些化合物的组合物以及包括给予这些化合物的治疗方法。